张予曦毕雯珺总算说上话了

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_蜘蛛资讯网

on of two primary efficacy endpoints. These simultaneously assessed cartilage regeneration through arthroscopy and patient-reported outcomes (PROs) for pain and functional improvement one year post-CA

ounced on Wednesday that its umbilical cord-derived allogeneic mesenchymal stem cell therapy, CARTISTEM®, has successfully met all primary and secondary efficacy endpoints in its Phase 3 clinical tria

当前文章：http://o2qo7.duzheke.cn/2wzgiq/3a1elf.html

发布时间：00:00:00